AIG and SolarEdge rise while Mylan and Phibro fall


Save Story

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:

American International Group Inc., up $3.19 to $50.30

The insurer reported solid underwriting gains in the first quarter and profit beat Wall Street forecasts.

Mylan NV, down $6.73 to $21.53

The generic drugmaker's first quarter revenue fell short of Wall Street forecasts.

Apple Inc., down $5.62 to 202.86

Technology stocks sold off amid an escalating trade fight between the U.S. and China.

The Mosaic Co., down $2.02 to $23.25

The fertilizer maker cut its full-year profit forecast because of higher costs for regulations and taxes.

Regeneron Pharmaceuticals Inc., down $21.83 to $322.40

The drugmaker's first quarter profit and revenue missed analysts' forecasts.

Phibro Animal Health Corp., down $7.86 to $28.99

The maker of animal health products and supplements fell short of Wall Street's profit and revenue forecasts.

SolarEdge Technologies Inc., up $9.96 to $53.84

The photovoltaic products maker gave investors a better-than-anticipated revenue forecast for the second quarter.

Henry Schein Inc., up $3.43 to $66.71

The health care products company beat Wall Street's first quarter profit and revenue forecasts.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

Business
The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast